News | Artificial Intelligence | December 06, 2018

YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018

Products include lung lesion detection, multimodal decision support for multiple cancers

YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018

December 6, 2018 — Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent Diagnostic and Treatment Platform for CancerScreening and Care.AI Intelligent 4D Imaging System for Chest CT, at the annual meeting of Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.

In particular, Care.AI Intelligent 4D Imaging System for Chest CT is the first AI system, according to YITU, to break through detection of pulmonary nodules and realize the real-time imaging of a wide variety of other lesions. Together with other cancer screening solutions, it will greatly reduce the workload of radiologists, become a clinical assistant to radiologists, and provide the possibility for large-scale early cancer screening worldwide, according to the company.

This comes amidst a backdrop of the latest Annual World Cancer Report, released by the World Health Organization (WHO) on Nov. 3, 2018. This year alone, it is expected that there will be 18.1 million new cancer cases and 9.6 million cancer deaths worldwide. The incidence of lung cancer, breast cancer, colorectal cancer, prostate cancer, gastric cancer, and other cancers is still growing rapidly and show no sign of slowing down.

China's medical AI has developed rapidly over a short period of time, but most companies focus on detection of pulmonary nodules, which only account for about 50 percent of lung lesions in a chest computed tomography (CT) scan. Prof. Zhengyu Jin, chairman of the Chinese Society of Radiology, said that products that can only detect lung nodules are not assistants to radiologists, as the complete clinical diagnosis process for chest CT imaging has to include other types of lesions such as patchy shadow, stripe shadow and cystic shadow.  

Care.AI Intelligent 4D Imaging System for Chest CT is a centralized display of the scientific research achievements made by YITU Healthcare in recent years, and can provide information sign analysis and diagnosis to achieve efficacy prediction and evaluation. Jin said this system basically realizes the full-dimensional detection of lesions for chest CT imaging, improves the functions of medical AI and promotes its application in clinical practice.

In addition to this product, Intelligent Diagnostic and Treatment Platform for Cancer Screening was also released at the same time, covering multiple cancers. This platform relies on YITU Healthcare's disease-centered massive multimodal medical data to provide doctors with imaging detection, lesion analysis, clinical decision-making assistance, patient management and other services.

For a long time, it has been difficult to widely promote large-scale early screening of diseases, especially cancer screening, restricted by the availability of limited high-quality medical resources, according to YITU. The emergence of high-level medical AI makes it possible for AI systems to assist doctors becoming providers of medical services to a certain extent and provides the possibility for large-scale early screening of tumors.

The YITU technology is being used in a large-scale cancer screening program called “AI Map for Cancer Screening” that recently launched in China, according to Cathy Fang, M.D., vice president of YITU Healthcare. At present, the program covers 19 provinces and autonomous regions in China, and coverage is still increasing. The preliminary screening results from a collaboration project between YITU Healthcare and the 2nd Affiliated Hospital of Guangzhou Medical University identified 10 cases of lung cancers out of over 1,300 high-risk people, including 9 early cancer patients, all of whom have been verified by pathological testing and are in a state of recovery after prompt treatment. This is the world's first time to use AI solutions on cancer screening on a large population, according to the company.

For more information: www.yitutech.com/en

Related Content

Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology services, announced a number of steps it is taking as part of its aggressive transformational activity to position the company for long-term, sustainable growth
News | Radiology Business | June 05, 2020
June 5, 2020 — Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p
The opportunity to converge the silos of data into a cross-functional analysis can provide immense value during the COVID-19 outbreak and in the future

Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Jeff Vachon
In the midst of the coronavirus pandemic normal
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...